Primary Site >> Esophagus Cancer

Gene >> MAP2K7

Journal: Oncogene. 2000 Mar 23;19(13):1665-75.
Title: Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway.
Author: Leu, C M|Chang, C|Hu, C
PMID: 10763823
Journal: J Biol Chem. 2001 May 4;276(18):15537-46. Epub 2001 Jan 31.
Title: Constitutive ERK1/2 activation in esophagogastric rib bone marrow micrometastatic cells is MEK-independent.
Author: Barry, O P|Mullan, B|Sheehan, D|Kazanietz, M G|Shanahan, F|Collins, J K|O'Sullivan, G C
PMID: 11297525
Journal: Biochem Pharmacol. 2004 May 1;67(9):1701-10.
Title: Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase.
Author: Sutter, Andreas P|Maaser, Kerstin|Gerst, Bastian|Krahn, Antje|Zeitz, Martin|Scherubl, Hans
PMID: 15081869
Journal: Anticancer Res. 2004 Mar-Apr;24(2B):811-9.
Title: Selective inhibition of survival signal transduction pathways enhanced radiosensitivity in human esophageal cancer cell lines in vitro.
Author: Akimoto, Tetsuo|Nonaka, Tetsuo|Harashima, Koichi|Ishikawa, Hitoshi|Sakurai, Hideyuki|Mitsuhashi, Norio
PMID: 15161032
Journal: J Biol Chem. 2004 Dec 3;279(49):50676-83. Epub 2004 Sep 16.
Title: The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation.
Author: Chang, Mei-Chi|Wu, Hui-Lin|Lee, Jang-Jaer|Lee, Po-Hsuen|Chang, Hsiao-Hwa|Hahn, Liang-Jiunn|Lin, Bor-Ru|Chen, Yi-Jane|Jeng, Jiiang-Huei
PMID: 15375172
Journal: Biochem Biophys Res Commun. 2006 Mar 31;342(1):286-92. Epub 2006 Feb 6.
Title: Differentiation-associated genes regulated by TPA-induced c-Jun expression via a PKC/JNK pathway in KYSE450 cells.
Author: Yu, Xinfeng|Luo, Aiping|Zhou, Changchun|Ding, Fang|Wu, Min|Zhan, Qimin|Liu, Zhihua
PMID: 16480952
Journal: Oral Oncol. 2007 Nov;43(10):1026-33.
Title: Up-regulation of matrix metalloproteinase-8 by betel quid extract and arecoline and its role in 2D motility.
Author: Liu, Shyun-Yeu|Liu, Young-Chau|Huang, Wen-Tsung|Huang, Guan-Cheng|Chen, Tai-Chi|Lin, Mei-Huei
PMID: 17306610
Journal: J Cell Biochem. 2008 Sep 1;105(1):53-60.
Title: Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
Author: Liu, Xuan|Wu, William K K|Yu, Le|Sung, Joseph J Y|Srivastava, Gopesh|Zhang, Shu T|Cho, Chi H
PMID: 18452159
Journal: Mol Biol Rep. 2011 Feb;38(2):865-72.
Title: The expression and activation of ERK/MAPK pathway in human esophageal cancer cell line EC9706.
Author: Zheng, Shu-Tao|Huo, Qi|Tuerxun, Aerziguli|Ma, Wen-Jing|Lv, Guo-Dong|Huang, Cong-Gai|Liu, Qing|Wang, Xing|Lin, Ren-Yong|Sheyhidin, Ilyar|Lu, Xiao-Mei
PMID: 20464500
Journal: PLoS One. 2011;6(10):e25806.
Title: BRAF mutations in advanced cancers: clinical characteristics and outcomes.
Author: El-Osta, Hazem|Falchook, Gerald|Tsimberidou, Apostolia|Hong, David|Naing, Aung|Kim, Kevin|Wen, Sijin|Janku, Filip|Kurzrock, Razelle
PMID: 22039425
Journal: Anticancer Res. 2012 Jul;32(7):2827-34.
Title: Esophageal cancer exhibits resistance to a novel IGF-1R inhibitor NVP-AEW541 with maintained RAS-MAPK activity.
Author: Bao, Xiao-Hong|Takaoka, Munenori|Hao, Hui-Fang|Wang, Zhi-Gang|Fukazawa, Takuya|Yamatsuji, Tomoki|Sakurama, Kazufumi|Sun, Dong-Sheng|Nagasaka, Takeshi|Fujiwara, Toshiyoshi|Naomoto, Yoshio
PMID: 22753744
Journal: Mol Carcinog. 2012 Oct;51(10):796-806.
Title: Downregulation of tropomyosin-1 in squamous cell carcinoma of esophagus, the role of Ras signaling and methylation.
Author: Zare, Maryam|Jazii, Ferdous Rastgar|Soheili, Zahra-Soheila|Moghanibashi, Mohamad-Mehdi
PMID: 22965424
Journal: Oncol Rep. 2013 Aug;30(2):739-44.
Title: Differentiation of immature DCs into endothelial-like cells in human esophageal carcinoma tissue homogenates.
Author: Lu, Jing|Bai, Ruihua|Qin, Zhenzhu|Zhang, Yanyan|Zhang, Xiaoyan|Jiang, Yanan|Yang, Hongyan|Huang, Youtian|Li, Gang|Zhao, Mingyao|Dong, Ziming
PMID: 23708958
Journal: Yao Xue Xue Bao. 2013 May;48(5):635-41.
Title: [Roles of targeting Ras/Raf/MEK/ERK signaling pathways in the treatment of esophageal carcinoma].
Author: Chang, Yu-Sui|Liu, Ji-Chun|Fu, Hua-Qun|Yu, Ben-Tong|Zou, Shu-Bing|Wu, Qi-Cai|Wan, Li
PMID: 23888683
Journal: Oncol Rep. 2014 Mar;31(3):1296-304.
Title: Overexpression of transferrin receptor CD71 and its tumorigenic properties in esophageal squamous cell carcinoma.
Author: Chan, Kin Tak|Choi, Mei Yuk|Lai, Kenneth K Y|Tan, Winnie|Tung, Lai Nar|Lam, Ho Yu|Tong, Daniel K H|Lee, Nikki P|Law, Simon
PMID: 24435655
Journal: Int J Clin Exp Pathol. 2014 Oct 15;7(11):7663-71. eCollection 2014.
Title: Aquaporin-8 mediates human esophageal cancer Eca-109 cell migration via the EGFR-Erk1/2 pathway.
Author: Chang, Heng|Shi, Yong-Hua|Talaf, Tuo-Kan|Lin, Chen
PMID: 25550802
Journal: Cancer Lett. 2014 Dec 1;355(1):34-45.
Title: Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.
Author: Yu, Le|Gu, Chunping|Zhong, Desheng|Shi, Lili|Kong, Yi|Zhou, Zhitao|Liu, Shuwen
PMID: 25236911
Journal: Int J Mol Sci. 2014 Jul 14;15(7):12422-41.
Title: DADS suppresses human esophageal xenograft tumors through RAF/MEK/ERK and mitochondria-dependent pathways.
Author: Yin, Xiaoran|Zhang, Jun|Li, Xiaoning|Liu, Dong|Feng, Cheng|Liang, Rongrui|Zhuang, Kun|Cai, Chenlei|Xue, Xinghuan|Jing, Fuchun|Wang, Xijing|Wang, Jun|Liu, Xinlian|Ma, Hongbing
PMID: 25026173
Journal: Am Soc Clin Oncol Educ Book. 2014:e172-8.
Title: New directions in perioperative management of locally advanced esophagogastric cancer.
Author: Burtness, Barbara|Ilson, David|Iqbal, Syma
PMID: 24857100
Journal: Invest New Drugs. 2015 Jun;33(3):641-51.
Title: Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.
Author: Nakamichi, Shinji|Nokihara, Hiroshi|Yamamoto, Noboru|Yamada, Yasuhide|Fujiwara, Yutaka|Tamura, Yosuke|Wakui, Hiroshi|Honda, Kazunori|Mizugaki, Hidenori|Kitazono, Satoru|Tanabe, Yuko|Asahina, Hajime|Yamazaki, Naoya|Suzuki, Shigenobu|Matsuoka, Mieko|Ogita,
PMID: 25809858
Journal: BMC Cancer. 2015 Jun 4;15:454.
Title: Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma.
Author: Gavine, Paul R|Wang, Mei|Yu, Dehua|Hu, Eva|Huang, Chunlei|Xia, Jenny|Su, Xinying|Fan, Joan|Zhang, Tianwei|Ye, Qingqing|Zheng, Li|Zhu, Guanshan|Qian, Ziliang|Luo, Qingquan|Hou, Ying Yong|Ji, Qunsheng
PMID: 26040563
Journal: Oncotarget. 2015 Dec 8;6(39):42183-96.
Title: Mutant HRAS as novel target for MEK and mTOR inhibitors.
Author: Kiessling, Michael K|Curioni-Fontecedro, Alessandra|Samaras, Panagiotis|Atrott, Kirstin|Cosin-Roger, Jesus|Lang, Silvia|Scharl, Michael|Rogler, Gerhard
PMID: 26544513
Journal: Cancer Chemother Pharmacol. 2016 Jan;77(1):99-108.
Title: A phase I study of two dosing schedules of oral BI 847325 in patients with advanced solid tumors.
Author: Schoffski, Patrick|Aftimos, Philippe|Dumez, Herlinde|Deleporte, Amelie|De Block, Katrien|Costermans, Jo|Billiet, Maureen|Meeus, Marie-Anne|Lee, Chooi|Schnell, David|Goeldner, Rainer-Georg|Awada, Ahmad
PMID: 26650227
Journal: Oncol Lett. 2016 Nov;12(5):3598-3608. Epub 2016 Sep 5.
Title: Antitumor activity of 7RH, a discoidin domain receptor 1 inhibitor, alone or in combination with dasatinib exhibits antitumor effects in nasopharyngeal carcinoma cells.
Author: Lu, Qiu-Ping|Chen, Wen-Dan|Peng, Jie-Ren|Xu, Yao-Dong|Cai, Qian|Feng, Gong-Kan|Ding, Ke|Zhu, Xiao-Feng|Guan, Zhong
PMID: 27900042
Journal: J Cell Biochem. 2017 Aug 31.
Title: FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma.
Author: Shi, Yuanyuan|Liu, Xuejiao|Fredimoses, Mangaladoss|Song, Mengqiu|Chen, Hanyong|Liu, Kangdong|Lee, Mee-Hyun|Dong, Zigang
PMID: 28857247
Journal: Drug Deliv. 2017 Nov;24(1):1549-1564.
Title: GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
Author: Pi, Jiang|Jiang, Jinhuan|Cai, Huaihong|Yang, Fen|Jin, Hua|Yang, Peihui|Cai, Jiye|Chen, Zheng W
PMID: 29019267
Journal: Molecules. 2018 Apr 17;23(4). pii: molecules23040930.
Title: Chemoresistance to Cancer Treatment: Benzo-alpha-Pyrene as Friend or Foe?
Author: Dzobo, Kevin|Hassen, Naseeha|Senthebane, Dimakatso Alice|Thomford, Nicholas Ekow|Rowe, Arielle|Shipanga, Hendrina|Wonkam, Ambroise|Parker, M Iqbal|Mowla, Shaheen|Dandara, Collet
PMID: 29673198
Journal: Cancer Res. 2018 Sep 1;78(17):4957-4970.
Title: IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment.
Author: Karakasheva, Tatiana A|Lin, Eric W|Tang, Qiaosi|Qiao, Edmund|Waldron, Todd J|Soni, Monica|Klein-Szanto, Andres J|Sahu, Varun|Basu, Devraj|Ohashi, Shinya|Baba, Kiichiro|Giaccone, Zachary T|Walker, Sarah R|Frank, David A|Wileyto, E Paul|Long, Qi|Dunagin, Ma
PMID: 29976575